Kinjal Patel

Employment

• Intas Pharmaceutical Limited (Biopharma Division) Research Scientist
  2017 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Discovery of Arginine Ethyl Ester as Polyglutamine Aggregation Inhibitor: Conformational Transitioning of Huntingtin N-Terminus Augments Aggregation Suppression
  ACS Chemical Neuroscience 2019 DOI: 10.1021/acschemneuro.9b00167
  +Save
• Designing aptamers which respond to intracellular oxidative stress and inhibit aggregation of mutant huntingtin
  Free Radical Biology and Medicine 2018 DOI: 10.1016/j.freeradbiomed.2018.03.052
  +Save
• Inhibition of aggregation of mutant huntingtin by nucleic acid aptamers in vitro and in a yeast model of huntington’s disease
  Gene Therapy in Neurological Disorders 2018 DOI: 10.1016/B978-0-12-809813-4.00010-7
  +Save
• RNA Aptamers Rescue Mitochondrial Dysfunction in a Yeast Model of Huntington's Disease
  Molecular Therapy - Nucleic Acids 2018 DOI: 10.1016/j.omtn.2018.04.010
  +Save
• Challenges with osmolytes as inhibitors of protein aggregation: Can nucleic acid aptamers provide an answer?
  International Journal of Biological Macromolecules 2017 DOI: 10.1016/j.ijbiomac.2016.05.014
  +Save
• Specific detection of tetanus toxoid using an aptamer-based matrix
  Journal of Biotechnology 2016 DOI: 10.1016/j.jbiotec.2016.09.004
  +Save
• Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers in Vitro and in a Yeast Model of Huntington's Disease
  Molecular Therapy 2015 DOI: 10.1038/mt.2015.157
  +Save